Similarly, intratumoral injection of recombinant human IL-12 in patients with head and neck squamous cell carcinoma (HNSCC) showed increased NK cells and IFNγ expression in the tumors and lymph nodes compared to the control arm, which correlated to the overall survival (86). Here, IFNG is linked to head and neck squamous cell carcinoma.